Início › Leucemia Linfoblástica Aguda › Texas
Ensaios clínicos de Leucemia Linfoblástica Aguda em Texas
30 estudos para Leucemia Linfoblástica Aguda estão buscando participantes em locais em Texas.
Cidades em Texas
Texto oficial do estudo (Inglês)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades de 12 a 78 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- MD Anderson Cancer Center, Houston
- Sarah Cannon Transplant and Cellular Therapy Methodist Hospital, San Antonio
RecrutandoFase 2
6 Months · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06514794Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Texas Children's Hospital, Houston
RecrutandoEstudo observacional
4 Weeks – 18 Years · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06308588A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Methodist Children's Hospital, San Antonio
RecrutandoFase 1
Idades de 0 a 18 · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06173518Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT05334069First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- e mais 10
RecrutandoFase 1/2
Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241A Study of CTD402 in T-ALL/LBL Patients
- MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 1 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07070219Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- University of Texas, Southwestern, Dallas
- Baylor Texas Children's Hospital, Houston
RecrutandoFase 2
Idades de 7 a 25 · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT05082519Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Baylor College of Medicine Houston, Houston
- The University of Texas Health Science Center at San Antonio, San Antonio
RecrutandoEstudo observacional
1 Day – 17 Years · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT06274788Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
- The University of Texas M. D. Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT07053059Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 15 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT03136146Personalized NK Cell Therapy in CBT
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades de 15 a 80 · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT02727803Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, Houston
RecrutandoFase 1/2
Idades 16 e acima · Todos os sexos · Atualizado em 20 de jul. de 2026 · NCT07155226Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Houston
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 13 de jul. de 2026 · NCT07109219A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
- Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
- e mais 5
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT01351545A Study of Revumenib and Mezigdomide in People With Leukemia
- MD Anderson Cancer Center (Data Collection Only), Houston
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT07356154Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
RecrutandoEstudo observacional
Idades de 0 a 38 · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT06131801TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- MD Anderson, Houston
- University of Texas Health Science Center San Antonio, San Antonio
RecrutandoFase 1/2
Até 1 anos · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05848687Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes
- University of Texas at Arlington Movement & Physical Activity Epidemiology Laboratory, Arlington
RecrutandoVoluntários saudáveis bem-vindos
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de mai. de 2026 · NCT06727942Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 20 de mai. de 2026 · NCT03263572Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 18 de mai. de 2026 · NCT01790152Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 13 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT04771572A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1501, Houston
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT06051409A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- MDACC, Houston
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 24 de mar. de 2026 · NCT04988555A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- MD Anderson, Houston
RecrutandoFase 2
Idades de 18 a 66 · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT06859424Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
RecrutandoFase 1
Até 75 anos · Todos os sexos · Atualizado em 5 de jan. de 2026 · NCT01853631Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 5 de nov. de 2025 · NCT04260022Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- University of Texas, Southwestern, Dallas
- Cook Children's Hospital, Fort Worth
- Texas Children's Hospital/Baylor College of Medicine, Houston
RecrutandoFase 1
Idades de 1 a 21 · Todos os sexos · Atualizado em 6 de dez. de 2024 · NCT05476770Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.